Drugs / Flu-IVIG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02008578 | Dec 2013 → Jun 2014 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flu-IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02008578 ↗ |
| Known as | hIVIG | “anti-influenza virus hyperimmune intravenous immunoglobulin (hIVIG)” PMID 26374911 ↗ Sep 2015 |
| Modality | Protein / enzyme biologic | “hyperimmune intravenous immunoglobulin” NCT02008578 ↗ |
| Route | Intravenous | “Intravenous hyperimmune immunoglobulin (Flu-IVIG)” NCT02008578 ↗ |